Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea

201714 citationsJournal Articlehybrid Open Access

Authors

Kyu-Bin Oh · The Genetics Society of Korea

Chul-Min Kim · Seoul St. Mary's Hospital

Abstract

Compared to PCV-13, PHiD-CV was projected to provide similar prevention against IPD and community-acquired pneumonia but would prevent more cases of AOM. Parity-priced PHiD-CV was anticipated to generate substantial cost-savings and health benefits vs. PCV-13 in Korea.

Topics & Keywords

Pneumonia and Respiratory Infections Bacterial Infections and Vaccines Gastroesophageal reflux and treatments

Publication Details

Published in: Human Vaccines & Immunotherapeutics

Volume 14, Issue 1, pp. 85-94

DOI: 10.1080/21645515.2017.1362513

Field-Weighted Citation Impact: 1.21

Command Palette

Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea

Authors

Abstract

Topics & Keywords

Publication Details